89bio Statistics
Total Valuation
89bio has a market cap or net worth of $884.66 million. The enterprise value is $482.26 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
89bio has 145.98 million shares outstanding. The number of shares has increased by 47.13% in one year.
| Current Share Class | 145.98M |
| Shares Outstanding | 145.98M |
| Shares Change (YoY) | +47.13% |
| Shares Change (QoQ) | +8.29% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 65.32% |
| Float | 107.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.81 |
| P/TBV Ratio | 2.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.19, with a Debt / Equity ratio of 0.09.
| Current Ratio | 13.19 |
| Quick Ratio | 12.18 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -72.71 |
Financial Efficiency
Return on equity (ROE) is -78.34% and return on invested capital (ROIC) is -48.00%.
| Return on Equity (ROE) | -78.34% |
| Return on Assets (ROA) | -44.73% |
| Return on Invested Capital (ROIC) | -48.00% |
| Return on Capital Employed (ROCE) | -86.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.95M |
| Employee Count | 93 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, 89bio has paid $692,000 in taxes.
| Income Tax | 692,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.27% in the last 52 weeks. The beta is 1.29, so 89bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -35.27% |
| 50-Day Moving Average | 8.40 |
| 200-Day Moving Average | 8.29 |
| Relative Strength Index (RSI) | 42.57 |
| Average Volume (20 Days) | 2,545,339 |
Short Selling Information
The latest short interest is 15.23 million, so 10.43% of the outstanding shares have been sold short.
| Short Interest | 15.23M |
| Short Previous Month | 11.01M |
| Short % of Shares Out | 10.43% |
| Short % of Float | 14.16% |
| Short Ratio (days to cover) | 7.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -384.66M |
| Pretax Income | -170.51M |
| Net Income | -367.08M |
| EBITDA | -384.62M |
| EBIT | -384.66M |
| Earnings Per Share (EPS) | -$3.51 |
Full Income StatementBalance Sheet
The company has $439.96 million in cash and $37.55 million in debt, giving a net cash position of $402.41 million or $2.76 per share.
| Cash & Cash Equivalents | 439.96M |
| Total Debt | 37.55M |
| Net Cash | 402.41M |
| Net Cash Per Share | $2.76 |
| Equity (Book Value) | 400.79M |
| Book Value Per Share | 3.34 |
| Working Capital | 440.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$367.82 million and capital expenditures -$15,000, giving a free cash flow of -$367.84 million.
| Operating Cash Flow | -367.82M |
| Capital Expenditures | -15,000 |
| Free Cash Flow | -367.84M |
| FCF Per Share | -$2.52 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |